Foundation Health has secured $20m in a Series A funding round to expand its AI-driven infrastructure for pharmacy operations.
The funding round was led by Define Ventures, with participation from Intermountain Ventures, Vanderbilt University and existing investors, bringing the company’s overall funding to $26m.
The proceeds will be used to grow sales and operations teams, accelerate development of its pharmacy technology suite and address rising demand from direct-to-consumer healthcare providers and health systems.
Foundation Health founder and CEO Umar Afridi stated: “Pharmacy's operational backbone hasn't evolved to meet today's patient expectations or system-level complexity.
“We built Foundation to be a modern infrastructure layer that helps care organisations, from large health systems to innovative D2C [direct to consumer] brands, deliver high-quality care with less friction. This funding enables us to scale rapidly and serve a broader range of partners."
The investment follows the launch of the company’s AI pharmacist assistant, PAIGE AI, designed to automate prior authorisation workflows and patient communications across pharmacy and medical benefits.
It is integrated with major electronic health records (EHRs) including Epic, and manages adherence outreach, refill processing, verification of benefits, medication onboarding and prior authorisation submissions. The system is HIPAA and SOC 2 compliant.
PAIGE automates repetitive tasks and minimises the workload of care team by up to 75%, expedites therapy initiation, enhances patient adherence and enables pharmacists to focus on complex clinical responsibilities.
Define Ventures founder and managing partner Lynne Chou O’Keefe stated: “Foundation Health is redefining what the pharmacy experience should look like in modern healthcare.
“Their approach is comprehensive, scaleable, and AI-native, and solves real pain points for pharmacists and patients. We're thrilled to back Umar and the team as they lead the next wave of AI-powered pharmacy operations.”
